GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Maz
|
ENSRNOG00000055082 | MYC associated zinc finger protein |
Zfp281
|
ENSRNOG00000058643 | zinc finger protein 281 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Maz | rn6_v1_chr1_-_198460126_198460126 | 0.10 | 8.1e-02 | Click! |
Zfp281 | rn6_v1_chr13_+_53506925_53506925 | 0.04 | 4.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_-_152641679 | 143.87 |
ENSRNOT00000080277
|
Gabra3
|
gamma-aminobutyric acid type A receptor alpha3 subunit |
chr1_-_215834704 | 79.99 |
ENSRNOT00000073850
|
Igf2
|
insulin-like growth factor 2 |
chr3_+_41019898 | 78.08 |
ENSRNOT00000007335
|
Kcnj3
|
potassium voltage-gated channel subfamily J member 3 |
chr4_-_71713063 | 78.05 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr4_-_169999873 | 71.34 |
ENSRNOT00000011697
|
Grin2b
|
glutamate ionotropic receptor NMDA type subunit 2B |
chrX_-_15707436 | 70.33 |
ENSRNOT00000085907
|
Syp
|
synaptophysin |
chr3_-_176666282 | 66.01 |
ENSRNOT00000016947
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr4_+_30807879 | 61.48 |
ENSRNOT00000013184
|
Dync1i1
|
dynein cytoplasmic 1 intermediate chain 1 |
chr1_-_42587666 | 60.96 |
ENSRNOT00000083225
ENSRNOT00000025355 |
Rgs17
|
regulator of G-protein signaling 17 |
chr1_-_72727112 | 58.32 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr9_+_99998275 | 55.98 |
ENSRNOT00000074395
|
Gpc1
|
glypican 1 |
chr3_-_176816114 | 55.24 |
ENSRNOT00000079262
ENSRNOT00000018697 |
Stmn3
|
stathmin 3 |
chr10_+_56627411 | 55.17 |
ENSRNOT00000089108
ENSRNOT00000068493 |
Dlg4
|
discs large MAGUK scaffold protein 4 |
chr18_-_17716880 | 54.69 |
ENSRNOT00000061151
|
Celf4
|
CUGBP, Elav-like family member 4 |
chr11_+_58624198 | 53.47 |
ENSRNOT00000002091
|
Gap43
|
growth associated protein 43 |
chr3_-_129357348 | 53.28 |
ENSRNOT00000084829
ENSRNOT00000007410 |
Pak7
|
p21 (RAC1) activated kinase 7 |
chr8_+_111600532 | 52.17 |
ENSRNOT00000081952
|
Rab6b
|
RAB6B, member RAS oncogene family |
chr1_-_81881549 | 51.68 |
ENSRNOT00000027497
|
Atp1a3
|
ATPase Na+/K+ transporting subunit alpha 3 |
chr19_-_56677084 | 51.28 |
ENSRNOT00000024084
|
Acta1
|
actin, alpha 1, skeletal muscle |
chr8_+_49418965 | 50.64 |
ENSRNOT00000021819
|
Scn2b
|
sodium voltage-gated channel beta subunit 2 |
chr18_+_56193978 | 50.42 |
ENSRNOT00000041533
ENSRNOT00000080177 |
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr6_+_105364668 | 49.87 |
ENSRNOT00000009513
ENSRNOT00000087090 |
Ttc9
|
tetratricopeptide repeat domain 9 |
chr10_-_109224370 | 49.59 |
ENSRNOT00000005839
|
Aatk
|
apoptosis-associated tyrosine kinase |
chr4_+_7076759 | 48.33 |
ENSRNOT00000066598
|
Smarcd3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
chr3_-_52510507 | 48.05 |
ENSRNOT00000091259
|
Scn1a
|
sodium voltage-gated channel alpha subunit 1 |
chr1_-_89360733 | 47.12 |
ENSRNOT00000028544
|
Mag
|
myelin-associated glycoprotein |
chr3_+_124515978 | 46.09 |
ENSRNOT00000028881
|
Prnp
|
prion protein |
chr10_-_47724499 | 46.05 |
ENSRNOT00000085011
|
Rnf112
|
ring finger protein 112 |
chrX_+_159112880 | 45.98 |
ENSRNOT00000084594
|
Fhl1
|
four and a half LIM domains 1 |
chr7_-_116607674 | 45.56 |
ENSRNOT00000076014
|
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr16_+_20691978 | 44.39 |
ENSRNOT00000038139
ENSRNOT00000082319 |
Tmem59l
|
transmembrane protein 59-like |
chr4_+_147686490 | 44.31 |
ENSRNOT00000014217
ENSRNOT00000086660 |
Cand2
|
cullin-associated and neddylation-dissociated 2 (putative) |
chr1_-_64405149 | 43.93 |
ENSRNOT00000089944
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7 |
chr2_-_29768750 | 43.53 |
ENSRNOT00000023460
|
Map1b
|
microtubule-associated protein 1B |
chr1_+_36185916 | 43.39 |
ENSRNOT00000041762
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr7_+_139698148 | 42.94 |
ENSRNOT00000078579
|
Pfkm
|
phosphofructokinase, muscle |
chr13_-_90676629 | 42.91 |
ENSRNOT00000058143
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2 |
chr5_+_140870140 | 42.78 |
ENSRNOT00000074347
|
Hpcal4
|
hippocalcin-like 4 |
chr2_+_95320283 | 42.73 |
ENSRNOT00000015537
|
Hey1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
chr19_-_11326139 | 42.55 |
ENSRNOT00000025669
|
Mt3
|
metallothionein 3 |
chr7_+_130431213 | 42.52 |
ENSRNOT00000055792
|
Mapk8ip2
|
mitogen-activated protein kinase 8 interacting protein 2 |
chr10_+_39655455 | 42.44 |
ENSRNOT00000058817
|
Acsl6
|
acyl-CoA synthetase long-chain family member 6 |
chr12_-_39958239 | 42.38 |
ENSRNOT00000050368
|
Myl2
|
myosin light chain 2 |
chr17_-_27969433 | 41.87 |
ENSRNOT00000073967
|
Nrn1
|
neuritin 1 |
chr10_+_70262361 | 41.59 |
ENSRNOT00000064625
ENSRNOT00000076973 |
Unc45b
|
unc-45 myosin chaperone B |
chr1_+_100447998 | 41.47 |
ENSRNOT00000026259
|
Lrrc4b
|
leucine rich repeat containing 4B |
chr2_+_113984646 | 41.14 |
ENSRNOT00000016799
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr1_-_140262452 | 40.98 |
ENSRNOT00000046849
ENSRNOT00000045165 ENSRNOT00000025536 ENSRNOT00000041839 |
Ntrk3
|
neurotrophic receptor tyrosine kinase 3 |
chr7_-_119441487 | 40.43 |
ENSRNOT00000067635
|
Pvalb
|
parvalbumin |
chrX_+_122808605 | 40.38 |
ENSRNOT00000017567
|
Zcchc12
|
zinc finger CCHC-type containing 12 |
chr3_-_143063983 | 40.30 |
ENSRNOT00000006329
|
Napb
|
NSF attachment protein beta |
chr10_-_82197848 | 40.07 |
ENSRNOT00000081307
|
Cacna1g
|
calcium voltage-gated channel subunit alpha1 G |
chr4_+_21317695 | 39.35 |
ENSRNOT00000007572
|
Grm3
|
glutamate metabotropic receptor 3 |
chrX_-_152642531 | 39.20 |
ENSRNOT00000085037
|
Gabra3
|
gamma-aminobutyric acid type A receptor alpha3 subunit |
chr4_-_157381105 | 39.12 |
ENSRNOT00000021670
|
Gpr162
|
G protein-coupled receptor 162 |
chr17_-_18592750 | 38.98 |
ENSRNOT00000065742
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr4_-_40385349 | 38.93 |
ENSRNOT00000039005
|
Gpr85
|
G protein-coupled receptor 85 |
chr4_+_110699557 | 38.68 |
ENSRNOT00000030588
ENSRNOT00000092261 |
Lrrtm4
|
leucine rich repeat transmembrane neuronal 4 |
chr3_+_56861396 | 38.37 |
ENSRNOT00000000008
ENSRNOT00000084375 |
Gad1
|
glutamate decarboxylase 1 |
chr1_+_134699299 | 38.18 |
ENSRNOT00000068766
|
Rgma
|
repulsive guidance molecule family member A |
chr19_+_561727 | 37.97 |
ENSRNOT00000016259
ENSRNOT00000081547 |
Rrad
|
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
chr4_-_52350624 | 37.94 |
ENSRNOT00000060476
|
Tmem229a
|
transmembrane protein 229A |
chr4_+_49941304 | 37.59 |
ENSRNOT00000008719
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1 |
chr1_+_215666628 | 37.49 |
ENSRNOT00000040598
ENSRNOT00000066135 ENSRNOT00000051425 ENSRNOT00000080339 ENSRNOT00000066896 ENSRNOT00000063918 |
Tnnt3
|
troponin T3, fast skeletal type |
chr12_+_28381982 | 37.48 |
ENSRNOT00000076101
|
Wbscr17
|
Williams-Beuren syndrome chromosome region 17 |
chr1_+_72889270 | 37.28 |
ENSRNOT00000058843
ENSRNOT00000034957 |
Tnnt1
|
troponin T1, slow skeletal type |
chr19_+_14653198 | 36.89 |
ENSRNOT00000020017
|
Rasd2
|
RASD family, member 2 |
chr1_+_12915734 | 36.75 |
ENSRNOT00000089066
|
Txlnb
|
taxilin beta |
chr10_+_90731865 | 36.69 |
ENSRNOT00000064429
|
Adam11
|
ADAM metallopeptidase domain 11 |
chr13_-_52197205 | 36.61 |
ENSRNOT00000009712
|
Shisa4
|
shisa family member 4 |
chr5_+_148193710 | 36.58 |
ENSRNOT00000088568
|
Adgrb2
|
adhesion G protein-coupled receptor B2 |
chr2_+_34186091 | 36.28 |
ENSRNOT00000016129
|
Sgtb
|
small glutamine rich tetratricopeptide repeat containing beta |
chr1_+_80195532 | 36.10 |
ENSRNOT00000022528
|
Rtn2
|
reticulon 2 |
chr7_-_116607408 | 36.01 |
ENSRNOT00000076009
ENSRNOT00000056554 |
Ly6h
|
lymphocyte antigen 6 complex, locus H |
chr6_+_64297888 | 35.44 |
ENSRNOT00000050222
ENSRNOT00000083088 ENSRNOT00000093147 |
Nrcam
|
neuronal cell adhesion molecule |
chr3_+_168345152 | 35.31 |
ENSRNOT00000017654
|
Dok5
|
docking protein 5 |
chr10_-_14056169 | 35.00 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chr3_-_161246351 | 34.91 |
ENSRNOT00000020348
|
Tnnc2
|
troponin C2, fast skeletal type |
chr19_+_54553419 | 34.73 |
ENSRNOT00000025392
|
Jph3
|
junctophilin 3 |
chr1_-_100530183 | 34.69 |
ENSRNOT00000067754
|
Mybpc2
|
myosin binding protein C, fast-type |
chr2_+_142262236 | 34.56 |
ENSRNOT00000019057
|
Lhfp
|
lipoma HMGIC fusion partner |
chr15_-_33629699 | 34.53 |
ENSRNOT00000023302
|
Myh6
|
myosin heavy chain 6 |
chr7_-_50638798 | 34.45 |
ENSRNOT00000048880
|
Syt1
|
synaptotagmin 1 |
chr1_+_100297152 | 34.38 |
ENSRNOT00000026100
|
Shank1
|
SH3 and multiple ankyrin repeat domains 1 |
chrX_-_78496847 | 34.28 |
ENSRNOT00000003265
|
Itm2a
|
integral membrane protein 2A |
chr18_+_83471342 | 34.26 |
ENSRNOT00000019384
|
Neto1
|
neuropilin and tolloid like 1 |
chr1_+_101682172 | 34.16 |
ENSRNOT00000028540
|
Car11
|
carbonic anhydrase 11 |
chr6_+_79254339 | 34.03 |
ENSRNOT00000073970
|
Sstr1
|
somatostatin receptor 1 |
chr10_-_57671080 | 33.90 |
ENSRNOT00000082511
|
LOC691995
|
hypothetical protein LOC691995 |
chr13_-_109997092 | 33.78 |
ENSRNOT00000005190
|
Nenf
|
neudesin neurotrophic factor |
chr1_-_102191287 | 33.75 |
ENSRNOT00000028696
ENSRNOT00000038798 |
Abcc8
|
ATP binding cassette subfamily C member 8 |
chr11_+_60072727 | 33.74 |
ENSRNOT00000090230
|
Tagln3
|
transgelin 3 |
chr2_+_113984824 | 33.68 |
ENSRNOT00000086399
|
Tnik
|
TRAF2 and NCK interacting kinase |
chr2_-_26699333 | 33.59 |
ENSRNOT00000024459
|
Sv2c
|
synaptic vesicle glycoprotein 2c |
chr1_-_215836641 | 33.53 |
ENSRNOT00000080246
|
Igf2
|
insulin-like growth factor 2 |
chr7_-_139063752 | 33.49 |
ENSRNOT00000072309
|
LOC102551901
|
protein lifeguard 2-like |
chr18_-_86878142 | 33.42 |
ENSRNOT00000058139
|
Dok6
|
docking protein 6 |
chr13_-_72367980 | 33.35 |
ENSRNOT00000003928
|
Cacna1e
|
calcium voltage-gated channel subunit alpha1 E |
chr14_+_39154529 | 33.06 |
ENSRNOT00000003191
|
Gabra4
|
gamma-aminobutyric acid type A receptor alpha4 subunit |
chr3_-_163935617 | 32.91 |
ENSRNOT00000074023
|
Kcnb1
|
potassium voltage-gated channel subfamily B member 1 |
chr13_+_89524329 | 32.65 |
ENSRNOT00000004279
|
Mpz
|
myelin protein zero |
chr5_+_147323240 | 32.60 |
ENSRNOT00000047152
|
Fndc5
|
fibronectin type III domain containing 5 |
chr10_-_56211891 | 32.33 |
ENSRNOT00000015076
|
Atp1b2
|
ATPase Na+/K+ transporting subunit beta 2 |
chr16_-_39719187 | 32.11 |
ENSRNOT00000092971
|
Gpm6a
|
glycoprotein m6a |
chr2_+_196295069 | 32.10 |
ENSRNOT00000088312
ENSRNOT00000028630 |
Tmod4
|
tropomodulin 4 |
chr12_+_39553903 | 32.08 |
ENSRNOT00000001738
|
Atp2a2
|
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
chr16_-_64778486 | 32.07 |
ENSRNOT00000031701
|
Rnf122
|
ring finger protein 122 |
chr15_+_344685 | 31.90 |
ENSRNOT00000065542
ENSRNOT00000066928 |
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1 |
chr4_-_157294047 | 31.87 |
ENSRNOT00000005601
|
Eno2
|
enolase 2 |
chr18_+_53915807 | 31.81 |
ENSRNOT00000026543
|
Adamts19
|
ADAM metallopeptidase with thrombospondin type 1 motif, 19 |
chr1_+_101161252 | 31.79 |
ENSRNOT00000028064
ENSRNOT00000064184 |
Slc17a7
|
solute carrier family 17 member 7 |
chr20_-_1984737 | 31.44 |
ENSRNOT00000040232
ENSRNOT00000051634 ENSRNOT00000079445 |
Gabbr1
|
gamma-aminobutyric acid type B receptor subunit 1 |
chr14_-_39112600 | 31.44 |
ENSRNOT00000003170
|
Gabrb1
|
gamma-aminobutyric acid type A receptor beta 1 subunit |
chr3_+_56862691 | 31.38 |
ENSRNOT00000087712
|
Gad1
|
glutamate decarboxylase 1 |
chr13_+_70379346 | 31.31 |
ENSRNOT00000038183
|
Nmnat2
|
nicotinamide nucleotide adenylyltransferase 2 |
chr1_+_39811314 | 31.21 |
ENSRNOT00000022046
|
Ppp1r14c
|
protein phosphatase 1, regulatory (inhibitor) subunit 14c |
chr8_+_7128656 | 31.15 |
ENSRNOT00000038313
|
Pgr
|
progesterone receptor |
chr10_+_57278307 | 31.01 |
ENSRNOT00000005612
|
Eno3
|
enolase 3 |
chr7_+_145117951 | 30.87 |
ENSRNOT00000055272
|
Pde1b
|
phosphodiesterase 1B |
chr2_-_164634434 | 30.83 |
ENSRNOT00000018402
|
Lxn
|
latexin |
chr10_+_65586993 | 30.81 |
ENSRNOT00000086036
|
Aldoc
|
aldolase, fructose-bisphosphate C |
chr1_+_78800754 | 30.50 |
ENSRNOT00000084601
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr7_-_141185710 | 30.46 |
ENSRNOT00000085033
|
Faim2
|
Fas apoptotic inhibitory molecule 2 |
chr8_+_119030875 | 30.45 |
ENSRNOT00000028458
|
Myl3
|
myosin light chain 3 |
chr5_-_109621170 | 30.35 |
ENSRNOT00000093007
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr1_+_221792221 | 30.24 |
ENSRNOT00000054828
|
Nrxn2
|
neurexin 2 |
chr19_-_11669578 | 30.09 |
ENSRNOT00000026373
|
Gnao1
|
G protein subunit alpha o1 |
chr15_+_17775692 | 30.06 |
ENSRNOT00000061169
|
LOC361016
|
similar to RIKEN cDNA 4933406L09 |
chr4_-_123040609 | 30.05 |
ENSRNOT00000070832
|
Wnt7a
|
wingless-type MMTV integration site family, member 7A |
chr19_+_52086325 | 29.82 |
ENSRNOT00000020341
|
Necab2
|
N-terminal EF-hand calcium binding protein 2 |
chr1_+_97632473 | 29.76 |
ENSRNOT00000023671
|
Vstm2b
|
V-set and transmembrane domain containing 2B |
chr4_+_155321553 | 29.76 |
ENSRNOT00000089614
|
Mfap5
|
microfibrillar associated protein 5 |
chr8_+_49441106 | 29.72 |
ENSRNOT00000030152
|
Scn4b
|
sodium voltage-gated channel beta subunit 4 |
chr15_-_28733513 | 29.67 |
ENSRNOT00000078180
|
Sall2
|
spalt-like transcription factor 2 |
chr2_-_210241455 | 29.66 |
ENSRNOT00000086420
|
Kcnc4
|
potassium voltage-gated channel subfamily C member 4 |
chr1_-_77808462 | 29.50 |
ENSRNOT00000078917
ENSRNOT00000080422 |
LOC103689961
|
selenoprotein W-like |
chr1_-_89560719 | 29.48 |
ENSRNOT00000028653
|
Scn1b
|
sodium voltage-gated channel beta subunit 1 |
chr1_-_198232344 | 29.45 |
ENSRNOT00000080988
|
Aldoa
|
aldolase, fructose-bisphosphate A |
chr6_-_94980004 | 29.44 |
ENSRNOT00000006373
|
Rtn1
|
reticulon 1 |
chr1_+_220668544 | 29.38 |
ENSRNOT00000039842
|
Gal3st3
|
galactose-3-O-sulfotransferase 3 |
chr1_+_88750462 | 29.25 |
ENSRNOT00000028247
|
LOC108348122
|
CAP-Gly domain-containing linker protein 3 |
chr20_-_4823475 | 29.15 |
ENSRNOT00000082536
ENSRNOT00000001114 |
Atp6v1g2
|
ATPase H+ transporting V1 subunit G2 |
chr1_-_102106127 | 29.13 |
ENSRNOT00000028685
|
Kcnj11
|
potassium voltage-gated channel subfamily J member 11 |
chr1_+_245237736 | 29.09 |
ENSRNOT00000035814
|
Vldlr
|
very low density lipoprotein receptor |
chr10_-_56167426 | 29.04 |
ENSRNOT00000013955
|
Efnb3
|
ephrin B3 |
chr9_+_82596355 | 28.91 |
ENSRNOT00000065076
|
Speg
|
SPEG complex locus |
chrX_-_22440187 | 28.76 |
ENSRNOT00000090731
|
Gpr173
|
|
chr1_+_215609645 | 28.72 |
ENSRNOT00000076140
ENSRNOT00000027487 |
Tnni2
|
troponin I2, fast skeletal type |
chr8_-_61290240 | 28.70 |
ENSRNOT00000023084
|
Lingo1
|
leucine rich repeat and Ig domain containing 1 |
chr10_-_86004096 | 28.51 |
ENSRNOT00000091978
ENSRNOT00000066855 |
Stac2
|
SH3 and cysteine rich domain 2 |
chr7_-_138039630 | 28.42 |
ENSRNOT00000008138
|
Slc38a1
|
solute carrier family 38, member 1 |
chr4_-_146016325 | 28.41 |
ENSRNOT00000067931
|
Atp2b2
|
ATPase plasma membrane Ca2+ transporting 2 |
chrX_-_118615798 | 28.39 |
ENSRNOT00000045463
|
Lrch2
|
leucine rich repeats and calponin homology domain containing 2 |
chr7_+_70364813 | 27.94 |
ENSRNOT00000084012
ENSRNOT00000031230 |
Agap2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr19_-_9801942 | 27.87 |
ENSRNOT00000051414
ENSRNOT00000017494 |
Ndrg4
|
NDRG family member 4 |
chrX_+_109940350 | 27.86 |
ENSRNOT00000093543
ENSRNOT00000057049 |
Nrk
|
Nik related kinase |
chr10_+_49000973 | 27.86 |
ENSRNOT00000057880
|
LOC102553715
|
microfibril-associated glycoprotein 4-like |
chr5_-_85123829 | 27.85 |
ENSRNOT00000007578
|
Brinp1
|
BMP/retinoic acid inducible neural specific 1 |
chr1_+_78025995 | 27.74 |
ENSRNOT00000086396
|
Slc8a2
|
solute carrier family 8 member A2 |
chr14_+_39663421 | 27.69 |
ENSRNOT00000003197
|
Gabra2
|
gamma-aminobutyric acid type A receptor alpha2 subunit |
chr1_+_101324652 | 27.59 |
ENSRNOT00000028116
|
Hrc
|
histidine rich calcium binding protein |
chr1_+_218466289 | 27.56 |
ENSRNOT00000017948
|
Mrgprf
|
MAS related GPR family member F |
chr4_+_33638709 | 27.51 |
ENSRNOT00000009888
ENSRNOT00000034719 ENSRNOT00000052333 |
Tac1
|
tachykinin, precursor 1 |
chr1_+_37507276 | 27.45 |
ENSRNOT00000047627
|
Adcy2
|
adenylate cyclase 2 |
chr12_-_22478752 | 27.43 |
ENSRNOT00000089392
ENSRNOT00000086915 |
Ache
|
acetylcholinesterase |
chr14_-_78902063 | 27.42 |
ENSRNOT00000088469
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr17_-_10766253 | 27.40 |
ENSRNOT00000000117
|
Cplx2
|
complexin 2 |
chr14_-_80958478 | 27.37 |
ENSRNOT00000035385
|
Dok7
|
docking protein 7 |
chr20_+_5535432 | 27.08 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr4_-_4473307 | 26.96 |
ENSRNOT00000045773
|
Dpp6
|
dipeptidyl peptidase like 6 |
chrX_+_106306795 | 26.95 |
ENSRNOT00000073661
|
Gprasp1
|
G protein-coupled receptor associated sorting protein 1 |
chr8_-_2045817 | 26.90 |
ENSRNOT00000009542
ENSRNOT00000081171 ENSRNOT00000078765 |
Gria4
|
glutamate ionotropic receptor AMPA type subunit 4 |
chr16_-_5795825 | 26.87 |
ENSRNOT00000048043
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
chr1_-_89560469 | 26.80 |
ENSRNOT00000079091
|
Scn1b
|
sodium voltage-gated channel beta subunit 1 |
chr2_-_123396386 | 26.74 |
ENSRNOT00000046700
|
Trpc3
|
transient receptor potential cation channel, subfamily C, member 3 |
chr15_+_344360 | 26.65 |
ENSRNOT00000077671
|
Kcnma1
|
potassium calcium-activated channel subfamily M alpha 1 |
chrX_-_136807885 | 26.61 |
ENSRNOT00000010325
|
Igsf1
|
immunoglobulin superfamily, member 1 |
chr13_+_31081804 | 26.54 |
ENSRNOT00000041413
|
Cdh7
|
cadherin 7 |
chr5_-_109651730 | 26.33 |
ENSRNOT00000093032
|
Elavl2
|
ELAV like RNA binding protein 2 |
chr15_-_33775109 | 26.28 |
ENSRNOT00000033722
|
Jph4
|
junctophilin 4 |
chr14_+_6994190 | 26.27 |
ENSRNOT00000020357
|
Sparcl1
|
SPARC like 1 |
chr3_+_129753742 | 26.10 |
ENSRNOT00000007998
ENSRNOT00000080581 |
Snap25
|
synaptosomal-associated protein 25 |
chr1_-_72461547 | 25.97 |
ENSRNOT00000022480
|
Ssc5d
|
scavenger receptor cysteine rich family member with 5 domains |
chr5_+_156876706 | 25.95 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr10_+_86657285 | 25.87 |
ENSRNOT00000087346
|
Thra
|
thyroid hormone receptor alpha |
chr3_-_105512939 | 25.85 |
ENSRNOT00000011773
|
Actc1
|
actin, alpha, cardiac muscle 1 |
chr20_+_10123651 | 25.68 |
ENSRNOT00000001559
|
Pde9a
|
phosphodiesterase 9A |
chr11_+_86512797 | 25.65 |
ENSRNOT00000051680
|
Gp1bb
|
glycoprotein Ib platelet beta subunit |
chr1_-_212548730 | 25.58 |
ENSRNOT00000089729
|
Caly
|
calcyon neuron-specific vesicular protein |
chr4_-_159287193 | 25.58 |
ENSRNOT00000080139
|
Kcna6
|
potassium voltage-gated channel subfamily A member 6 |
chr10_+_47765432 | 25.48 |
ENSRNOT00000078231
|
LOC102553715
|
microfibril-associated glycoprotein 4-like |
chr1_-_77535681 | 25.46 |
ENSRNOT00000018559
|
Selenow
|
selenoprotein W |
chr1_-_195096460 | 25.45 |
ENSRNOT00000077253
|
Snrpn
|
small nuclear ribonucleoprotein polypeptide N |
chr13_+_52889737 | 25.43 |
ENSRNOT00000074366
|
Cacna1s
|
calcium voltage-gated channel subunit alpha1 S |
chr17_-_88037034 | 25.37 |
ENSRNOT00000080193
ENSRNOT00000034907 |
Prtfdc1
|
phosphoribosyl transferase domain containing 1 |
chr8_-_98738446 | 25.26 |
ENSRNOT00000019860
|
Zic1
|
Zic family member 1 |
chr12_-_5822874 | 25.20 |
ENSRNOT00000075920
|
Fry
|
FRY microtubule binding protein |
chr1_-_90978907 | 25.16 |
ENSRNOT00000072819
|
Clip3
|
CAP-GLY domain containing linker protein 3 |
chr1_-_64433636 | 25.03 |
ENSRNOT00000080032
|
Prkcg
|
protein kinase C, gamma |
chr1_+_262905570 | 25.02 |
ENSRNOT00000090765
|
Kcnip2
|
potassium voltage-gated channel interacting protein 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
26.2 | 78.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
25.8 | 77.3 | GO:0060082 | eye blink reflex(GO:0060082) |
25.1 | 75.3 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
24.4 | 121.8 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
21.5 | 86.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
21.4 | 42.7 | GO:1905242 | response to 3,3',5-triiodo-L-thyronine(GO:1905242) cellular response to 3,3',5-triiodo-L-thyronine(GO:1905243) |
19.7 | 59.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
19.3 | 57.9 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
18.7 | 93.4 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
18.7 | 130.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
18.4 | 18.4 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
18.4 | 55.1 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
18.3 | 55.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
18.3 | 73.2 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
18.0 | 215.5 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
17.7 | 53.2 | GO:0010265 | SCF complex assembly(GO:0010265) |
17.3 | 52.0 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
17.1 | 51.3 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
16.5 | 49.6 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
16.0 | 144.4 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
15.9 | 47.7 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
15.8 | 63.1 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
15.6 | 31.1 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
15.2 | 121.5 | GO:0046958 | nonassociative learning(GO:0046958) |
15.1 | 60.4 | GO:0098953 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) protein localization to postsynaptic specialization membrane(GO:0099633) neurotransmitter receptor localization to postsynaptic specialization membrane(GO:0099645) |
14.6 | 73.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
14.6 | 43.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
14.0 | 84.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
13.9 | 83.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
13.8 | 41.4 | GO:1902303 | negative regulation of potassium ion export(GO:1902303) |
12.5 | 525.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
12.4 | 24.8 | GO:0072714 | response to selenite ion(GO:0072714) |
12.3 | 49.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
12.2 | 109.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
12.1 | 36.3 | GO:2001055 | embryonic nail plate morphogenesis(GO:0035880) positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
11.9 | 47.7 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
11.9 | 23.9 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
11.4 | 11.4 | GO:0046541 | saliva secretion(GO:0046541) |
11.4 | 34.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
11.4 | 45.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
11.2 | 33.6 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
10.9 | 10.9 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
10.7 | 43.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
10.5 | 10.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
10.4 | 31.3 | GO:0007412 | axon target recognition(GO:0007412) |
10.4 | 31.3 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
10.4 | 31.1 | GO:1904700 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
10.3 | 31.0 | GO:0021917 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
10.3 | 30.9 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
10.2 | 51.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
10.1 | 30.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
10.0 | 30.0 | GO:0006178 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
9.7 | 38.7 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
9.7 | 19.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
9.7 | 29.0 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
9.6 | 9.6 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
9.6 | 57.5 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
9.0 | 18.0 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
8.8 | 26.5 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
8.8 | 44.1 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
8.8 | 26.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
8.8 | 43.8 | GO:2000327 | positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
8.7 | 26.2 | GO:0071313 | cellular response to caffeine(GO:0071313) |
8.7 | 60.8 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
8.7 | 86.6 | GO:0016198 | axon choice point recognition(GO:0016198) |
8.6 | 43.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
8.6 | 51.6 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
8.6 | 68.8 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
8.5 | 67.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
8.4 | 33.8 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
8.4 | 58.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
8.3 | 25.0 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
8.3 | 25.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
8.3 | 24.9 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
8.3 | 24.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
8.3 | 24.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
8.3 | 24.8 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
8.2 | 24.7 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
8.1 | 32.3 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
8.0 | 16.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
8.0 | 31.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
7.8 | 109.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
7.8 | 70.0 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
7.8 | 31.0 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
7.6 | 15.1 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
7.6 | 45.4 | GO:0006868 | glutamine transport(GO:0006868) |
7.5 | 75.4 | GO:1901660 | calcium ion export(GO:1901660) |
7.5 | 22.5 | GO:1990523 | bone regeneration(GO:1990523) |
7.5 | 97.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
7.4 | 29.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
7.4 | 14.9 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
7.4 | 37.0 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
7.4 | 44.4 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
7.4 | 7.4 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
7.2 | 36.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
7.2 | 57.8 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
7.2 | 21.5 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
7.1 | 7.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
7.1 | 28.2 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
7.0 | 21.1 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
7.0 | 13.9 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
6.9 | 27.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
6.9 | 34.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
6.8 | 27.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
6.8 | 20.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
6.8 | 40.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
6.7 | 26.7 | GO:1901906 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
6.7 | 53.3 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
6.6 | 39.8 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
6.6 | 59.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
6.5 | 19.6 | GO:0071298 | cellular response to L-ascorbic acid(GO:0071298) |
6.5 | 19.6 | GO:0070946 | neutrophil mediated killing of gram-positive bacterium(GO:0070946) |
6.5 | 45.6 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
6.5 | 26.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
6.4 | 32.0 | GO:2000851 | positive regulation of glucocorticoid secretion(GO:2000851) |
6.4 | 19.2 | GO:0046333 | octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
6.3 | 12.7 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
6.3 | 19.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
6.3 | 131.5 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
6.2 | 18.7 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
6.2 | 6.2 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
6.1 | 79.9 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
6.1 | 24.5 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
6.1 | 12.3 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
6.1 | 30.6 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
6.1 | 30.5 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
6.1 | 6.1 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
6.1 | 85.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
6.1 | 18.3 | GO:0060988 | lipid tube assembly(GO:0060988) |
6.0 | 18.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
5.9 | 17.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
5.9 | 178.0 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
5.9 | 5.9 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
5.8 | 35.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
5.8 | 52.4 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
5.8 | 5.8 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
5.8 | 34.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
5.8 | 11.5 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
5.7 | 22.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
5.7 | 22.7 | GO:0007525 | somatic muscle development(GO:0007525) |
5.7 | 17.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
5.6 | 11.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
5.6 | 22.5 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
5.6 | 11.1 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
5.5 | 16.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
5.5 | 27.7 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
5.5 | 11.0 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
5.5 | 16.5 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
5.5 | 11.0 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
5.5 | 16.5 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
5.5 | 5.5 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
5.5 | 16.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
5.4 | 21.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
5.4 | 32.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
5.4 | 16.1 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
5.3 | 16.0 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
5.3 | 58.3 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
5.3 | 42.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
5.3 | 5.3 | GO:0048389 | intermediate mesoderm development(GO:0048389) pattern specification involved in mesonephros development(GO:0061227) anterior/posterior pattern specification involved in kidney development(GO:0072098) |
5.3 | 36.8 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
5.1 | 30.7 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
5.1 | 5.1 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) |
5.0 | 15.0 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
5.0 | 30.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
5.0 | 188.4 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
4.9 | 49.3 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
4.9 | 39.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
4.9 | 19.7 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
4.9 | 14.8 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
4.9 | 29.5 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
4.9 | 14.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
4.9 | 24.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
4.9 | 9.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
4.8 | 4.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
4.8 | 14.5 | GO:2000682 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
4.8 | 28.9 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
4.8 | 14.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
4.8 | 4.8 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
4.8 | 38.3 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
4.8 | 76.1 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
4.7 | 28.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
4.7 | 18.7 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
4.7 | 4.7 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
4.6 | 9.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
4.6 | 22.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
4.6 | 36.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
4.6 | 13.7 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
4.6 | 4.6 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
4.5 | 13.6 | GO:1990743 | protein sialylation(GO:1990743) |
4.5 | 13.6 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
4.5 | 18.1 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
4.5 | 22.4 | GO:0030070 | insulin processing(GO:0030070) |
4.5 | 26.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
4.5 | 4.5 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
4.4 | 35.6 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
4.4 | 17.7 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
4.4 | 26.5 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
4.4 | 13.2 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
4.4 | 8.8 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
4.3 | 13.0 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
4.3 | 17.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
4.3 | 25.8 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
4.3 | 8.6 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) positive regulation of renin secretion into blood stream(GO:1900135) |
4.3 | 25.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
4.2 | 12.7 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
4.2 | 4.2 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
4.2 | 16.9 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
4.2 | 29.5 | GO:0061620 | NADH regeneration(GO:0006735) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
4.2 | 67.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
4.2 | 41.8 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
4.2 | 12.5 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
4.2 | 16.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.2 | 12.5 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
4.1 | 28.8 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
4.1 | 12.3 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
4.1 | 16.4 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
4.1 | 16.4 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
4.1 | 12.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
4.0 | 16.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
4.0 | 8.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
4.0 | 12.1 | GO:0098971 | anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
4.0 | 12.0 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
4.0 | 12.0 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
4.0 | 31.9 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
4.0 | 31.9 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
4.0 | 15.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
3.9 | 15.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.9 | 7.9 | GO:0051124 | regulation of synaptic growth at neuromuscular junction(GO:0008582) synaptic growth at neuromuscular junction(GO:0051124) |
3.9 | 55.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
3.9 | 7.9 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
3.9 | 74.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
3.9 | 3.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
3.9 | 27.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
3.9 | 7.8 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.9 | 19.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
3.9 | 19.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
3.9 | 46.4 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
3.8 | 7.7 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
3.8 | 7.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
3.8 | 3.8 | GO:0060134 | prepulse inhibition(GO:0060134) |
3.8 | 34.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
3.8 | 7.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
3.8 | 49.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
3.7 | 33.5 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
3.7 | 22.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
3.7 | 3.7 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
3.7 | 14.8 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
3.7 | 7.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
3.7 | 3.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
3.6 | 40.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
3.6 | 21.8 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
3.6 | 40.0 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
3.6 | 7.2 | GO:0033058 | directional locomotion(GO:0033058) |
3.6 | 35.9 | GO:0007614 | short-term memory(GO:0007614) |
3.6 | 39.2 | GO:0099612 | protein localization to axon(GO:0099612) |
3.5 | 7.1 | GO:0098926 | postsynaptic signal transduction(GO:0098926) |
3.5 | 17.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
3.5 | 7.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
3.5 | 10.5 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
3.5 | 10.5 | GO:0048749 | compound eye development(GO:0048749) |
3.5 | 7.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
3.5 | 48.8 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
3.5 | 6.9 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
3.5 | 17.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
3.5 | 24.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
3.4 | 10.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
3.4 | 13.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
3.4 | 3.4 | GO:0021586 | pons maturation(GO:0021586) |
3.4 | 13.5 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
3.4 | 20.1 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
3.3 | 10.0 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
3.3 | 13.4 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
3.3 | 186.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
3.3 | 3.3 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
3.3 | 23.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
3.3 | 9.9 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
3.3 | 6.6 | GO:0003139 | secondary heart field specification(GO:0003139) |
3.3 | 13.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
3.3 | 9.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.3 | 19.6 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
3.3 | 9.8 | GO:0001964 | startle response(GO:0001964) |
3.3 | 22.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
3.2 | 6.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
3.2 | 54.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
3.2 | 54.5 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
3.2 | 9.6 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
3.2 | 3.2 | GO:0008355 | olfactory learning(GO:0008355) |
3.2 | 12.7 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
3.2 | 3.2 | GO:0019740 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) |
3.2 | 167.7 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
3.2 | 9.5 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
3.2 | 28.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
3.2 | 6.3 | GO:0071625 | vocalization behavior(GO:0071625) |
3.2 | 31.5 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
3.1 | 128.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
3.1 | 46.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
3.1 | 3.1 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
3.1 | 15.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
3.1 | 18.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
3.1 | 12.4 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
3.1 | 180.0 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
3.1 | 12.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
3.1 | 9.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
3.1 | 9.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
3.1 | 9.2 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
3.0 | 6.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
3.0 | 9.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
3.0 | 12.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
3.0 | 39.4 | GO:0009629 | response to gravity(GO:0009629) |
3.0 | 9.0 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
3.0 | 12.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
3.0 | 3.0 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
3.0 | 3.0 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
3.0 | 115.2 | GO:0021762 | substantia nigra development(GO:0021762) |
2.9 | 8.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
2.9 | 26.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
2.9 | 8.7 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
2.9 | 2.9 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
2.9 | 25.8 | GO:0032099 | negative regulation of appetite(GO:0032099) |
2.9 | 17.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
2.9 | 34.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
2.8 | 8.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
2.8 | 14.2 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
2.8 | 14.2 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
2.8 | 17.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
2.8 | 34.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
2.8 | 11.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
2.8 | 2.8 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
2.8 | 5.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
2.8 | 19.6 | GO:0060346 | bone trabecula formation(GO:0060346) |
2.8 | 8.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
2.8 | 16.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
2.8 | 11.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
2.8 | 5.6 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
2.8 | 16.6 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
2.7 | 8.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
2.7 | 16.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
2.7 | 8.2 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
2.7 | 8.2 | GO:0042756 | drinking behavior(GO:0042756) |
2.7 | 65.0 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
2.7 | 8.1 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.7 | 18.9 | GO:0007512 | adult heart development(GO:0007512) |
2.7 | 21.5 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
2.7 | 21.4 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
2.6 | 13.2 | GO:0097332 | response to antipsychotic drug(GO:0097332) |
2.6 | 5.3 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
2.6 | 2.6 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
2.6 | 2.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
2.6 | 5.2 | GO:0071503 | response to heparin(GO:0071503) |
2.6 | 5.2 | GO:1900126 | regulation of hyaluronan biosynthetic process(GO:1900125) negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.6 | 41.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.6 | 10.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.6 | 5.2 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
2.6 | 2.6 | GO:0007619 | courtship behavior(GO:0007619) |
2.6 | 2.6 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
2.6 | 15.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
2.6 | 61.6 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
2.6 | 161.7 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
2.5 | 10.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
2.5 | 73.5 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
2.5 | 25.3 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
2.5 | 5.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
2.5 | 7.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
2.5 | 5.0 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
2.5 | 42.8 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
2.5 | 10.0 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.5 | 2.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.5 | 4.9 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.5 | 7.4 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
2.5 | 14.8 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
2.5 | 4.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
2.4 | 9.8 | GO:0044211 | CTP salvage(GO:0044211) |
2.4 | 7.3 | GO:2000328 | regulation of T-helper 17 cell lineage commitment(GO:2000328) |
2.4 | 4.9 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
2.4 | 7.3 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
2.4 | 38.7 | GO:0070831 | basement membrane assembly(GO:0070831) |
2.4 | 4.8 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
2.4 | 7.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.4 | 21.4 | GO:0051451 | myoblast migration(GO:0051451) |
2.4 | 9.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
2.4 | 4.8 | GO:0048664 | neuron fate determination(GO:0048664) |
2.4 | 9.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
2.4 | 14.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.4 | 9.5 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
2.3 | 14.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
2.3 | 2.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
2.3 | 4.7 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
2.3 | 2.3 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
2.3 | 30.4 | GO:0045475 | locomotor rhythm(GO:0045475) |
2.3 | 13.9 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
2.3 | 16.1 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
2.3 | 31.9 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
2.3 | 31.8 | GO:0010107 | potassium ion import(GO:0010107) |
2.3 | 9.1 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
2.3 | 45.4 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
2.3 | 2.3 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
2.3 | 22.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
2.2 | 24.7 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
2.2 | 42.7 | GO:0014850 | response to muscle activity(GO:0014850) |
2.2 | 2.2 | GO:0032328 | alanine transport(GO:0032328) |
2.2 | 13.4 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
2.2 | 17.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.2 | 6.7 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) |
2.2 | 8.9 | GO:0048484 | enteric nervous system development(GO:0048484) |
2.2 | 6.7 | GO:0060214 | endocardium formation(GO:0060214) |
2.2 | 11.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.2 | 26.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
2.2 | 6.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
2.2 | 2.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
2.2 | 13.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
2.2 | 11.0 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
2.2 | 6.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.2 | 4.4 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
2.2 | 15.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
2.2 | 10.9 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
2.2 | 23.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
2.2 | 8.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.2 | 4.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
2.2 | 21.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
2.2 | 10.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
2.1 | 6.4 | GO:0030186 | melatonin metabolic process(GO:0030186) |
2.1 | 8.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.1 | 12.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
2.1 | 10.5 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
2.1 | 8.4 | GO:0061743 | motor learning(GO:0061743) |
2.1 | 4.2 | GO:0060594 | mammary gland specification(GO:0060594) |
2.1 | 16.6 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
2.1 | 10.3 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
2.1 | 8.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
2.1 | 45.2 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
2.0 | 4.1 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
2.0 | 2.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
2.0 | 22.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
2.0 | 12.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
2.0 | 2.0 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
2.0 | 8.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.0 | 2.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
2.0 | 6.0 | GO:1902856 | microtubule sliding(GO:0051012) negative regulation of nonmotile primary cilium assembly(GO:1902856) |
2.0 | 8.0 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
2.0 | 6.0 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
2.0 | 7.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
2.0 | 5.9 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
2.0 | 5.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.0 | 5.9 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
1.9 | 13.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
1.9 | 21.0 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
1.9 | 5.7 | GO:0060174 | limb bud formation(GO:0060174) |
1.9 | 20.8 | GO:0006465 | signal peptide processing(GO:0006465) |
1.9 | 17.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.9 | 39.4 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
1.9 | 3.8 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
1.9 | 3.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
1.9 | 3.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.9 | 3.7 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
1.8 | 5.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
1.8 | 9.2 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) L-lysine transmembrane transport(GO:1903401) |
1.8 | 11.0 | GO:0071105 | response to interleukin-11(GO:0071105) |
1.8 | 7.3 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.8 | 14.4 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
1.8 | 16.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.8 | 3.6 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
1.8 | 9.0 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.8 | 1.8 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
1.8 | 16.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.8 | 5.3 | GO:0071259 | hormone-mediated apoptotic signaling pathway(GO:0008628) cellular response to magnetism(GO:0071259) |
1.8 | 17.7 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
1.8 | 1.8 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.8 | 8.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
1.8 | 8.8 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
1.8 | 5.3 | GO:0046154 | eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) rhodopsin metabolic process(GO:0046154) |
1.7 | 1.7 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.7 | 10.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.7 | 3.4 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
1.7 | 10.2 | GO:0015074 | DNA integration(GO:0015074) |
1.7 | 5.1 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
1.7 | 5.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
1.7 | 1.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.7 | 3.4 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
1.7 | 10.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 5.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
1.7 | 6.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
1.7 | 3.3 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
1.7 | 3.3 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
1.6 | 4.9 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.6 | 6.6 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
1.6 | 3.3 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
1.6 | 16.3 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.6 | 4.9 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
1.6 | 38.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
1.6 | 4.8 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.6 | 30.6 | GO:0030239 | myofibril assembly(GO:0030239) |
1.6 | 6.4 | GO:0003383 | apical constriction(GO:0003383) |
1.6 | 1.6 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.6 | 4.8 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.6 | 4.8 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
1.6 | 4.8 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.6 | 22.3 | GO:0001675 | acrosome assembly(GO:0001675) |
1.6 | 11.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.6 | 14.1 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.6 | 3.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.6 | 28.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
1.6 | 10.9 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
1.6 | 10.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
1.5 | 4.6 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
1.5 | 4.6 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
1.5 | 3.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.5 | 7.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.5 | 9.1 | GO:0030815 | negative regulation of cAMP metabolic process(GO:0030815) |
1.5 | 1.5 | GO:0070459 | prolactin secretion(GO:0070459) |
1.5 | 1.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
1.5 | 3.0 | GO:0061642 | chemoattraction of axon(GO:0061642) renal outer medulla development(GO:0072054) |
1.5 | 1.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
1.5 | 6.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
1.5 | 48.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.5 | 1.5 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
1.5 | 3.0 | GO:0010138 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
1.5 | 4.5 | GO:0051546 | keratinocyte migration(GO:0051546) |
1.5 | 7.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
1.5 | 1.5 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.5 | 5.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.5 | 8.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.4 | 2.9 | GO:0030913 | paranodal junction assembly(GO:0030913) |
1.4 | 2.9 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
1.4 | 5.8 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.4 | 24.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
1.4 | 2.8 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) spermine acetylation(GO:0032919) |
1.4 | 4.3 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
1.4 | 26.5 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
1.4 | 4.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
1.4 | 29.3 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
1.4 | 2.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.4 | 15.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.4 | 5.5 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.4 | 6.8 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
1.4 | 4.1 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
1.3 | 4.0 | GO:1903660 | negative regulation of complement-dependent cytotoxicity(GO:1903660) |
1.3 | 4.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
1.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
1.3 | 5.3 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
1.3 | 1.3 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
1.3 | 29.3 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
1.3 | 2.7 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.3 | 5.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.3 | 1.3 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
1.3 | 9.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
1.3 | 9.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
1.3 | 3.9 | GO:1901374 | acetate ester transport(GO:1901374) |
1.3 | 3.9 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
1.3 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.3 | 2.6 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
1.3 | 3.8 | GO:0090172 | microtubule cytoskeleton organization involved in homologous chromosome segregation(GO:0090172) |
1.3 | 2.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
1.3 | 10.2 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
1.3 | 11.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
1.3 | 6.3 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.3 | 5.0 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.3 | 6.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.2 | 3.7 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
1.2 | 1.2 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
1.2 | 9.9 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
1.2 | 6.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.2 | 6.2 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.2 | 6.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
1.2 | 6.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
1.2 | 4.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
1.2 | 6.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.2 | 2.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.2 | 1.2 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
1.2 | 9.7 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.2 | 1.2 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
1.2 | 12.0 | GO:0044819 | mitotic G1 DNA damage checkpoint(GO:0031571) mitotic G1/S transition checkpoint(GO:0044819) |
1.2 | 8.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
1.2 | 4.8 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
1.2 | 3.6 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate catabolic process(GO:0006533) glutamate catabolic process(GO:0006538) |
1.2 | 3.6 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
1.2 | 2.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
1.2 | 10.7 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
1.2 | 3.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
1.2 | 7.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.2 | 7.0 | GO:0045622 | regulation of T-helper cell differentiation(GO:0045622) |
1.2 | 2.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
1.2 | 4.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.2 | 36.0 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
1.2 | 2.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.2 | 4.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
1.1 | 10.3 | GO:0035524 | proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
1.1 | 15.9 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
1.1 | 3.4 | GO:0008038 | neuron recognition(GO:0008038) |
1.1 | 5.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 1.1 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
1.1 | 3.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.1 | 10.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.1 | 5.7 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
1.1 | 3.4 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.1 | 2.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
1.1 | 1.1 | GO:0051595 | response to methylglyoxal(GO:0051595) |
1.1 | 7.9 | GO:0016322 | neuron remodeling(GO:0016322) |
1.1 | 1.1 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
1.1 | 3.4 | GO:0038203 | TORC2 signaling(GO:0038203) |
1.1 | 3.3 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
1.1 | 4.5 | GO:0070836 | caveola assembly(GO:0070836) |
1.1 | 10.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
1.1 | 1.1 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
1.1 | 7.8 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.1 | 1.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
1.1 | 2.2 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
1.1 | 7.7 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
1.1 | 4.4 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.1 | 24.1 | GO:0071539 | protein localization to centrosome(GO:0071539) |
1.1 | 3.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
1.1 | 3.3 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.1 | 3.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
1.1 | 6.5 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
1.1 | 2.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.1 | 7.5 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.1 | 3.2 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.1 | 7.4 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.1 | 6.4 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.1 | 44.4 | GO:0031109 | microtubule polymerization or depolymerization(GO:0031109) |
1.1 | 1.1 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.1 | 2.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.1 | 1.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
1.1 | 10.5 | GO:0032274 | gonadotropin secretion(GO:0032274) |
1.1 | 9.5 | GO:0098743 | cell aggregation(GO:0098743) |
1.0 | 4.2 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
1.0 | 7.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
1.0 | 17.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
1.0 | 1.0 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
1.0 | 3.1 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
1.0 | 11.2 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
1.0 | 60.1 | GO:0007612 | learning(GO:0007612) |
1.0 | 13.2 | GO:0021860 | pyramidal neuron development(GO:0021860) |
1.0 | 8.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
1.0 | 2.0 | GO:0036337 | Fas signaling pathway(GO:0036337) |
1.0 | 2.0 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.0 | 23.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
1.0 | 2.0 | GO:0018343 | protein farnesylation(GO:0018343) |
1.0 | 8.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.0 | 2.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
1.0 | 5.0 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.0 | 3.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.0 | 1.0 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
1.0 | 7.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.0 | 3.9 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
1.0 | 4.8 | GO:0042026 | protein refolding(GO:0042026) |
1.0 | 9.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
1.0 | 3.8 | GO:0051031 | tRNA transport(GO:0051031) |
0.9 | 3.7 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.9 | 3.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.9 | 1.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.9 | 6.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.9 | 6.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.9 | 1.8 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.9 | 2.7 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.9 | 1.8 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.9 | 4.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.9 | 8.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.9 | 1.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.9 | 0.9 | GO:0009644 | response to high light intensity(GO:0009644) |
0.9 | 2.7 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.9 | 8.0 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.9 | 28.4 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.9 | 12.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.9 | 15.0 | GO:0097435 | fibril organization(GO:0097435) |
0.9 | 8.8 | GO:0042501 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) serine phosphorylation of STAT protein(GO:0042501) |
0.9 | 1.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.9 | 1.8 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.9 | 1.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.9 | 0.9 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.9 | 1.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.9 | 11.4 | GO:0007628 | adult walking behavior(GO:0007628) |
0.9 | 6.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.9 | 11.3 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.9 | 3.5 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.9 | 6.1 | GO:0031269 | pseudopodium assembly(GO:0031269) |
0.9 | 1.7 | GO:0050955 | thermoception(GO:0050955) |
0.9 | 2.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.9 | 2.6 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.9 | 17.2 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.9 | 12.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.9 | 1.7 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
0.8 | 11.9 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.8 | 0.8 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.8 | 3.4 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.8 | 5.9 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.8 | 3.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.8 | 8.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.8 | 2.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.8 | 20.6 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.8 | 15.6 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.8 | 5.7 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.8 | 4.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 2.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.8 | 2.4 | GO:0060180 | female mating behavior(GO:0060180) |
0.8 | 4.8 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.8 | 4.0 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.8 | 9.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.8 | 1.6 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
0.8 | 3.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.8 | 4.7 | GO:0034184 | positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.8 | 0.8 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
0.8 | 2.3 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
0.8 | 3.9 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.8 | 1.6 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.8 | 2.3 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.8 | 6.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.8 | 3.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.7 | 10.5 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.7 | 6.7 | GO:0003352 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) |
0.7 | 5.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.7 | 4.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.7 | 2.2 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.7 | 1.4 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.7 | 3.6 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.7 | 5.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.7 | 10.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 0.7 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.7 | 3.5 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.7 | 4.9 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.7 | 2.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.7 | 0.7 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.7 | 2.8 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.7 | 1.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 | 2.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.7 | 6.8 | GO:0033622 | integrin activation(GO:0033622) |
0.7 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.7 | 2.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.7 | 2.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.7 | 2.0 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.7 | 2.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.7 | 6.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.7 | 79.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 2.0 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.7 | 13.3 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 8.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.7 | 6.5 | GO:0000338 | protein deneddylation(GO:0000338) |
0.7 | 1.3 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
0.6 | 1.3 | GO:2000078 | positive regulation of type B pancreatic cell development(GO:2000078) |
0.6 | 11.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.6 | 5.2 | GO:0055001 | muscle cell development(GO:0055001) |
0.6 | 0.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 62.8 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.6 | 5.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.6 | 5.6 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.6 | 10.0 | GO:0097503 | sialylation(GO:0097503) |
0.6 | 0.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 13.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.6 | 1.2 | GO:1904177 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.6 | 2.4 | GO:0042853 | L-alanine catabolic process(GO:0042853) |
0.6 | 4.2 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.6 | 0.6 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.6 | 1.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.6 | 2.4 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.6 | 2.9 | GO:0007100 | mitotic centrosome separation(GO:0007100) regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 2.9 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.6 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.6 | 1.2 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.6 | 1.7 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.6 | 1.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.6 | 3.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.6 | 27.4 | GO:0007631 | feeding behavior(GO:0007631) |
0.6 | 2.8 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.6 | 5.6 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.6 | 1.1 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.6 | 2.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.6 | 6.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.6 | 1.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 42.6 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.5 | 28.3 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.5 | 1.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 0.5 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
0.5 | 2.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
0.5 | 3.7 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.5 | 1.6 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.5 | 3.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.5 | 3.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.5 | 2.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 2.0 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.5 | 8.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.5 | 13.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.5 | 0.5 | GO:0060751 | branch elongation involved in mammary gland duct branching(GO:0060751) |
0.5 | 1.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.5 | 1.5 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.5 | 1.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.5 | 0.5 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.5 | 1.0 | GO:0001757 | somite specification(GO:0001757) |
0.5 | 3.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.5 | 1.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 5.8 | GO:0031167 | rRNA methylation(GO:0031167) |
0.5 | 2.9 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.5 | 1.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.5 | 3.3 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.5 | 2.3 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.5 | 1.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 1.8 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.5 | 2.3 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.5 | 2.3 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.5 | 2.3 | GO:0048070 | regulation of developmental pigmentation(GO:0048070) |
0.4 | 6.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.4 | 1.8 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.4 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 1.3 | GO:0032264 | IMP salvage(GO:0032264) |
0.4 | 5.7 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.4 | 1.8 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.4 | 0.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 1.7 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.4 | 2.2 | GO:2000345 | regulation of hepatocyte proliferation(GO:2000345) negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 1.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.4 | 1.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.4 | 1.3 | GO:0006567 | threonine catabolic process(GO:0006567) |
0.4 | 0.8 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 2.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.4 | 1.7 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.4 | 1.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.2 | GO:0048489 | synaptic vesicle transport(GO:0048489) establishment of synaptic vesicle localization(GO:0097480) |
0.4 | 0.8 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 2.0 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.4 | 0.4 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.4 | 1.2 | GO:0071000 | response to magnetism(GO:0071000) |
0.4 | 2.0 | GO:0061709 | reticulophagy(GO:0061709) |
0.4 | 24.9 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.4 | 2.3 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.4 | 10.5 | GO:0034605 | cellular response to heat(GO:0034605) |
0.4 | 1.2 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 4.3 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.4 | 3.4 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.4 | 1.9 | GO:0060736 | prostate gland growth(GO:0060736) |
0.4 | 1.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.4 | 2.6 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.4 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.4 | 6.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.4 | 1.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.4 | 1.5 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.4 | 8.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.4 | 2.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.7 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.4 | 1.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.3 | 4.5 | GO:0036065 | fucosylation(GO:0036065) |
0.3 | 2.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.3 | 0.7 | GO:0006788 | heme oxidation(GO:0006788) |
0.3 | 1.7 | GO:2000725 | regulation of cardiac muscle cell differentiation(GO:2000725) |
0.3 | 1.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 0.6 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.3 | 3.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 1.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.3 | 3.2 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 0.6 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
0.3 | 1.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.3 | 0.6 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.3 | 3.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.3 | 0.3 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.3 | 4.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 2.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.3 | 2.5 | GO:0021794 | thalamus development(GO:0021794) |
0.3 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.3 | 3.6 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.3 | 13.4 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.3 | 3.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 0.9 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.5 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.3 | 0.9 | GO:0097484 | dendrite extension(GO:0097484) |
0.3 | 2.6 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 1.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.3 | 3.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.3 | 0.6 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.3 | 1.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 0.8 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.3 | 0.8 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 5.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 1.3 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.3 | 0.8 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.3 | 0.5 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.3 | 1.6 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.3 | 0.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.3 | 0.5 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.3 | 0.3 | GO:0021533 | cell differentiation in hindbrain(GO:0021533) |
0.3 | 1.3 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.3 | 0.8 | GO:0000962 | mitochondrial mRNA catabolic process(GO:0000958) positive regulation of mitochondrial RNA catabolic process(GO:0000962) mitochondrial RNA 3'-end processing(GO:0000965) |
0.3 | 12.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.3 | 1.3 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.2 | 1.5 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 1.5 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.2 | 0.7 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.2 | 4.4 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 2.4 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) |
0.2 | 0.9 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.2 | 0.2 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.2 | 0.7 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.2 | 0.7 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 2.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 4.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.2 | 0.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.9 | GO:0070528 | protein kinase C signaling(GO:0070528) |
0.2 | 0.4 | GO:0045105 | intermediate filament polymerization or depolymerization(GO:0045105) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 1.1 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.2 | 0.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.2 | 1.1 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.2 | 1.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.2 | 0.6 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 2.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 2.2 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 5.3 | GO:0042073 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.2 | 1.0 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.2 | 0.6 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.6 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.2 | 0.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.2 | 3.1 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.2 | 0.8 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 0.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.8 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.5 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.2 | 5.0 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.2 | 0.9 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 2.9 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 2.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.2 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 3.4 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.3 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.2 | 2.2 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.5 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 0.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.1 | 11.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.4 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 0.3 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 3.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 0.8 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 1.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.1 | 0.9 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 1.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.1 | 0.8 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.6 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.1 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 0.2 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.1 | 0.7 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.6 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 6.8 | GO:0098916 | chemical synaptic transmission(GO:0007268) anterograde trans-synaptic signaling(GO:0098916) |
0.1 | 1.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 8.5 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
0.1 | 0.1 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.1 | 0.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.3 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
0.1 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.6 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.1 | 2.0 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.4 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) |
0.1 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.1 | 1.5 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 1.9 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.2 | GO:0035600 | tRNA methylthiolation(GO:0035600) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 5.3 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
0.1 | 0.1 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.3 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.1 | 0.4 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 0.4 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.2 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.6 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.8 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.9 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.3 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.0 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.6 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.2 | GO:0051294 | establishment of spindle orientation(GO:0051294) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.2 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
22.2 | 66.7 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
21.9 | 65.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
20.2 | 242.8 | GO:0005861 | troponin complex(GO:0005861) |
17.9 | 53.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
17.1 | 51.4 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
17.0 | 51.1 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) calcium ion-transporting ATPase complex(GO:0090534) |
16.7 | 250.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
16.6 | 49.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
15.2 | 349.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
14.6 | 145.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
14.3 | 42.9 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
13.7 | 27.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
13.2 | 119.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
12.8 | 64.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
12.4 | 61.8 | GO:0072534 | perineuronal net(GO:0072534) |
12.2 | 244.6 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
12.2 | 255.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
11.2 | 67.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
11.1 | 122.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
10.3 | 31.0 | GO:0032173 | septin collar(GO:0032173) |
10.3 | 61.8 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
10.0 | 129.8 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
9.8 | 39.1 | GO:0097513 | myosin II filament(GO:0097513) |
9.5 | 9.5 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
9.2 | 74.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
9.2 | 9.2 | GO:0044301 | climbing fiber(GO:0044301) |
9.1 | 36.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
9.0 | 27.1 | GO:0098855 | HCN channel complex(GO:0098855) |
9.0 | 9.0 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
8.9 | 44.6 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
8.5 | 247.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
8.2 | 16.5 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
8.1 | 64.9 | GO:0097450 | astrocyte end-foot(GO:0097450) |
7.3 | 14.7 | GO:0044299 | C-fiber(GO:0044299) |
7.2 | 150.3 | GO:0043194 | axon initial segment(GO:0043194) |
7.2 | 686.8 | GO:0034705 | potassium channel complex(GO:0034705) |
7.0 | 13.9 | GO:0097444 | spine apparatus(GO:0097444) |
6.9 | 55.2 | GO:0032584 | growth cone membrane(GO:0032584) |
6.8 | 67.6 | GO:0032591 | dendritic spine membrane(GO:0032591) |
6.7 | 20.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
6.5 | 19.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
6.4 | 19.3 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
6.4 | 275.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
6.4 | 19.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
6.4 | 6.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
6.4 | 12.7 | GO:0098845 | postsynaptic endosome(GO:0098845) |
6.1 | 18.4 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
5.9 | 58.8 | GO:0043083 | synaptic cleft(GO:0043083) |
5.7 | 23.0 | GO:0044308 | axonal spine(GO:0044308) |
5.7 | 17.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
5.7 | 22.8 | GO:0005607 | laminin-2 complex(GO:0005607) |
5.6 | 16.9 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
5.6 | 22.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.5 | 11.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
5.5 | 77.2 | GO:0031045 | dense core granule(GO:0031045) |
5.3 | 143.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
5.2 | 5.2 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
5.2 | 68.1 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
4.9 | 54.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
4.8 | 202.2 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
4.8 | 86.2 | GO:0031430 | M band(GO:0031430) |
4.8 | 28.5 | GO:0005955 | calcineurin complex(GO:0005955) |
4.7 | 23.4 | GO:0005927 | muscle tendon junction(GO:0005927) |
4.7 | 28.1 | GO:0008091 | spectrin(GO:0008091) |
4.7 | 23.3 | GO:0071953 | elastic fiber(GO:0071953) |
4.6 | 13.9 | GO:0045242 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
4.6 | 13.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
4.4 | 22.2 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
4.4 | 70.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
4.4 | 8.7 | GO:0005940 | septin ring(GO:0005940) |
4.3 | 17.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
4.3 | 60.4 | GO:0032590 | dendrite membrane(GO:0032590) |
4.3 | 34.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
4.2 | 17.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
4.2 | 25.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
4.1 | 12.4 | GO:0060187 | cell pole(GO:0060187) |
4.0 | 28.3 | GO:0097449 | astrocyte projection(GO:0097449) |
4.0 | 43.9 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
4.0 | 47.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
3.9 | 23.3 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
3.8 | 15.4 | GO:0000322 | storage vacuole(GO:0000322) |
3.8 | 57.6 | GO:0071565 | nBAF complex(GO:0071565) |
3.8 | 118.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
3.8 | 64.7 | GO:0016528 | sarcoplasm(GO:0016528) |
3.7 | 211.0 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
3.6 | 10.9 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
3.5 | 10.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
3.4 | 13.8 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
3.4 | 126.8 | GO:0044295 | axonal growth cone(GO:0044295) |
3.4 | 3.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
3.4 | 40.3 | GO:0005796 | Golgi lumen(GO:0005796) |
3.3 | 6.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
3.3 | 9.9 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.2 | 9.6 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
3.1 | 15.6 | GO:0016012 | sarcoglycan complex(GO:0016012) |
3.1 | 9.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
3.1 | 119.4 | GO:0043198 | dendritic shaft(GO:0043198) |
3.0 | 63.8 | GO:0031672 | A band(GO:0031672) |
3.0 | 456.9 | GO:0030427 | site of polarized growth(GO:0030427) |
3.0 | 12.0 | GO:0033269 | internode region of axon(GO:0033269) |
3.0 | 340.3 | GO:0030017 | sarcomere(GO:0030017) |
2.9 | 20.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
2.8 | 19.8 | GO:0005869 | dynactin complex(GO:0005869) |
2.8 | 50.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
2.8 | 11.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
2.8 | 2.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
2.8 | 41.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
2.8 | 11.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
2.7 | 21.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.7 | 2.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
2.6 | 15.3 | GO:1990246 | uniplex complex(GO:1990246) |
2.5 | 76.1 | GO:0005921 | gap junction(GO:0005921) |
2.5 | 17.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.5 | 15.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
2.5 | 15.1 | GO:0043203 | axon hillock(GO:0043203) |
2.5 | 29.7 | GO:0005687 | U4 snRNP(GO:0005687) |
2.4 | 7.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
2.4 | 89.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
2.4 | 7.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
2.4 | 62.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
2.3 | 4.6 | GO:0005683 | U7 snRNP(GO:0005683) |
2.3 | 29.3 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
2.2 | 11.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
2.2 | 404.1 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
2.2 | 21.6 | GO:0031527 | filopodium membrane(GO:0031527) |
2.1 | 19.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
2.1 | 10.5 | GO:1990393 | 3M complex(GO:1990393) |
2.1 | 6.2 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
2.0 | 46.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
2.0 | 6.1 | GO:0005916 | fascia adherens(GO:0005916) |
2.0 | 2.0 | GO:0032982 | myosin filament(GO:0032982) |
2.0 | 5.9 | GO:0071437 | invadopodium(GO:0071437) |
1.9 | 95.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.9 | 43.4 | GO:0030016 | myofibril(GO:0030016) |
1.9 | 129.6 | GO:0098794 | postsynapse(GO:0098794) |
1.9 | 13.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
1.9 | 26.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
1.9 | 3.7 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.9 | 7.4 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.8 | 32.6 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
1.8 | 5.4 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
1.8 | 1.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.8 | 3.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
1.8 | 8.9 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.7 | 13.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.7 | 9.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.6 | 268.7 | GO:0098793 | presynapse(GO:0098793) |
1.6 | 12.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.6 | 20.7 | GO:0097440 | apical dendrite(GO:0097440) |
1.5 | 4.6 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
1.5 | 6.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.5 | 7.6 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
1.5 | 9.0 | GO:0031209 | SCAR complex(GO:0031209) |
1.5 | 6.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.5 | 14.9 | GO:0005871 | kinesin complex(GO:0005871) |
1.5 | 7.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
1.4 | 8.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
1.4 | 5.6 | GO:0044456 | synapse part(GO:0044456) |
1.4 | 37.4 | GO:0043679 | axon terminus(GO:0043679) |
1.4 | 51.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
1.4 | 28.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.3 | 8.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.3 | 30.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.3 | 13.2 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
1.3 | 83.1 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
1.3 | 3.9 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
1.3 | 10.3 | GO:0016272 | prefoldin complex(GO:0016272) |
1.3 | 30.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.2 | 1.2 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
1.2 | 25.9 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.2 | 3.7 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
1.2 | 48.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
1.2 | 6.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
1.2 | 13.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
1.1 | 66.5 | GO:0042383 | sarcolemma(GO:0042383) |
1.1 | 6.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.1 | 3.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
1.1 | 1.1 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.1 | 4.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.1 | 8.8 | GO:0042587 | glycogen granule(GO:0042587) |
1.1 | 4.4 | GO:0034657 | GID complex(GO:0034657) |
1.1 | 14.2 | GO:0000124 | SAGA complex(GO:0000124) |
1.1 | 4.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.1 | 3.2 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.1 | 106.8 | GO:0030424 | axon(GO:0030424) |
1.1 | 3.2 | GO:0033503 | HULC complex(GO:0033503) |
1.1 | 141.0 | GO:0043209 | myelin sheath(GO:0043209) |
1.1 | 2.1 | GO:0042583 | chromaffin granule(GO:0042583) |
1.0 | 5.2 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
1.0 | 5.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.0 | 18.5 | GO:0001891 | phagocytic cup(GO:0001891) |
1.0 | 4.1 | GO:0071797 | LUBAC complex(GO:0071797) |
1.0 | 8.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.0 | 7.1 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
1.0 | 5.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.0 | 4.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.0 | 28.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
1.0 | 7.8 | GO:0034709 | methylosome(GO:0034709) |
1.0 | 4.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
1.0 | 2.9 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.9 | 2.8 | GO:0043511 | inhibin complex(GO:0043511) |
0.9 | 81.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.9 | 8.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.9 | 2.7 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.9 | 7.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.9 | 278.0 | GO:0043025 | neuronal cell body(GO:0043025) |
0.9 | 2.6 | GO:0045203 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
0.8 | 7.5 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 4.0 | GO:0002141 | stereocilia ankle link(GO:0002141) |
0.8 | 8.6 | GO:0097542 | ciliary tip(GO:0097542) |
0.8 | 81.6 | GO:0045202 | synapse(GO:0045202) |
0.7 | 7.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.7 | 8.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.7 | 4.3 | GO:0030891 | VCB complex(GO:0030891) |
0.7 | 15.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 7.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.7 | 1.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 2.0 | GO:0071942 | XPC complex(GO:0071942) |
0.7 | 2.6 | GO:0097196 | Shu complex(GO:0097196) |
0.7 | 12.5 | GO:0019013 | viral nucleocapsid(GO:0019013) |
0.6 | 2.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.6 | 4.2 | GO:0070469 | respiratory chain(GO:0070469) |
0.6 | 6.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.6 | 2.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.6 | 16.3 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.6 | 1.7 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.6 | 5.1 | GO:0002177 | manchette(GO:0002177) |
0.5 | 1.6 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.5 | 1.6 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.5 | 2.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.5 | 6.5 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.5 | 1.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 1.5 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 2.9 | GO:0061617 | MICOS complex(GO:0061617) |
0.5 | 5.8 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.5 | 2.4 | GO:0097255 | R2TP complex(GO:0097255) |
0.5 | 29.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.5 | 0.9 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.5 | 8.3 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
0.5 | 2.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.5 | 123.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.4 | 12.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.4 | 1.3 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.4 | 2.9 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 10.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.4 | 1.2 | GO:1990879 | CST complex(GO:1990879) |
0.4 | 4.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 2.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 8.3 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.4 | 5.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.4 | 1.1 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 1.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 15.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.4 | 1.8 | GO:0071817 | MMXD complex(GO:0071817) CIA complex(GO:0097361) |
0.4 | 2.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.4 | 7.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.4 | 1.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 2.5 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 2.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.3 | 24.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 7.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.3 | 5.9 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 1.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.3 | 3.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 5.9 | GO:0090568 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 2.8 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.3 | 0.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.3 | 0.5 | GO:0070069 | cytochrome complex(GO:0070069) |
0.3 | 0.8 | GO:0045025 | mitochondrial degradosome(GO:0045025) |
0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.2 | 2.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 8.9 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 0.9 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 28.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 0.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.2 | 2.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.2 | 0.5 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.2 | 6.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.7 | GO:1990752 | microtubule end(GO:1990752) |
0.2 | 0.7 | GO:1990745 | GARP complex(GO:0000938) EARP complex(GO:1990745) |
0.2 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 24.3 | GO:0005874 | microtubule(GO:0005874) |
0.2 | 0.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 4.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.1 | 7.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.5 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 7.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 3.4 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.4 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.2 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.2 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.2 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.8 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.0 | 0.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.0 | 1.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 1.4 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.2 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.0 | 0.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
25.1 | 100.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
21.2 | 169.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
20.3 | 121.6 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
19.8 | 99.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
19.5 | 117.0 | GO:0031014 | troponin T binding(GO:0031014) |
19.3 | 77.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
19.1 | 57.3 | GO:0035939 | microsatellite binding(GO:0035939) |
18.5 | 37.0 | GO:0030172 | troponin C binding(GO:0030172) |
18.1 | 90.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
16.5 | 82.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
15.8 | 47.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
15.7 | 47.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
15.0 | 104.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
14.0 | 42.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
13.7 | 54.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
13.6 | 354.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
13.6 | 40.9 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
12.9 | 64.7 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
12.6 | 50.5 | GO:1903135 | cupric ion binding(GO:1903135) |
12.5 | 37.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
12.4 | 61.8 | GO:0070052 | collagen V binding(GO:0070052) |
12.3 | 49.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
11.5 | 46.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
11.3 | 45.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
11.3 | 79.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
11.3 | 67.6 | GO:0045503 | dynein light chain binding(GO:0045503) |
11.2 | 11.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
11.1 | 55.5 | GO:0051373 | FATZ binding(GO:0051373) |
11.1 | 77.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
10.7 | 42.9 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
10.7 | 53.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
10.4 | 31.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
10.3 | 61.8 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
9.9 | 79.0 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
9.6 | 28.9 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
9.6 | 57.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
9.4 | 28.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
9.4 | 28.2 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
9.3 | 37.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
9.3 | 28.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
9.2 | 27.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
9.0 | 36.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
9.0 | 27.0 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
8.0 | 16.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
7.8 | 46.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
7.4 | 59.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
7.4 | 37.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
7.3 | 65.8 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
7.2 | 50.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
7.0 | 21.1 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
7.0 | 27.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
6.9 | 34.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
6.9 | 96.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
6.8 | 95.8 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
6.7 | 27.0 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
6.7 | 33.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
6.7 | 26.7 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
6.7 | 46.7 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
6.5 | 19.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
6.5 | 84.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
6.4 | 19.2 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
6.3 | 19.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
6.3 | 125.9 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
6.3 | 31.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
6.2 | 24.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
6.1 | 182.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
6.0 | 77.9 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
5.9 | 17.8 | GO:0030977 | taurine binding(GO:0030977) |
5.9 | 41.0 | GO:0097001 | ceramide binding(GO:0097001) |
5.8 | 40.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
5.8 | 93.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
5.8 | 29.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
5.7 | 34.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
5.6 | 50.8 | GO:0031432 | titin binding(GO:0031432) |
5.6 | 22.4 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
5.6 | 16.7 | GO:0048030 | disaccharide binding(GO:0048030) |
5.6 | 22.2 | GO:0043404 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
5.5 | 16.6 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
5.5 | 44.1 | GO:1990459 | transferrin receptor binding(GO:1990459) |
5.4 | 32.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
5.4 | 48.5 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
5.4 | 21.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
5.4 | 26.8 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
5.3 | 100.8 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
5.3 | 42.3 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
5.2 | 62.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
5.1 | 5.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
5.1 | 50.7 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
5.0 | 25.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
5.0 | 10.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
5.0 | 94.7 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) |
5.0 | 84.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
4.9 | 133.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
4.9 | 14.8 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
4.9 | 19.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
4.9 | 97.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
4.9 | 14.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
4.7 | 14.2 | GO:0033222 | xylose binding(GO:0033222) |
4.7 | 23.4 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
4.7 | 158.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
4.6 | 13.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
4.5 | 18.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
4.5 | 13.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
4.5 | 26.9 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
4.5 | 17.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.4 | 35.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
4.4 | 17.7 | GO:0036004 | GAF domain binding(GO:0036004) |
4.4 | 52.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
4.4 | 26.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.4 | 13.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
4.4 | 61.2 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
4.4 | 13.1 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
4.3 | 60.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
4.2 | 12.7 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
4.2 | 17.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
4.1 | 45.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
4.0 | 4.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
4.0 | 48.3 | GO:0033691 | sialic acid binding(GO:0033691) |
4.0 | 16.0 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
3.9 | 15.8 | GO:0099609 | microtubule lateral binding(GO:0099609) |
3.9 | 15.7 | GO:0045159 | myosin II binding(GO:0045159) |
3.9 | 46.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.8 | 18.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
3.7 | 70.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
3.7 | 51.9 | GO:0051378 | serotonin binding(GO:0051378) |
3.7 | 33.2 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
3.7 | 25.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.7 | 62.1 | GO:0035254 | glutamate receptor binding(GO:0035254) |
3.6 | 25.5 | GO:0034711 | inhibin binding(GO:0034711) |
3.6 | 7.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
3.6 | 25.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
3.5 | 10.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.5 | 3.5 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
3.5 | 80.3 | GO:0031489 | myosin V binding(GO:0031489) |
3.5 | 17.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
3.5 | 13.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
3.5 | 13.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
3.4 | 3.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
3.4 | 99.9 | GO:0003785 | actin monomer binding(GO:0003785) |
3.4 | 20.3 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
3.4 | 50.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
3.3 | 16.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
3.3 | 33.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
3.3 | 19.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
3.3 | 13.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
3.3 | 13.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
3.2 | 35.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
3.2 | 9.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
3.2 | 9.5 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
3.1 | 9.3 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
3.1 | 18.7 | GO:0071253 | connexin binding(GO:0071253) |
3.1 | 31.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
3.1 | 34.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
3.1 | 15.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
3.1 | 3.1 | GO:0031433 | telethonin binding(GO:0031433) |
3.1 | 12.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
3.1 | 43.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
3.0 | 48.8 | GO:0030552 | cAMP binding(GO:0030552) |
3.0 | 3.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
3.0 | 12.0 | GO:0098821 | BMP receptor activity(GO:0098821) |
3.0 | 9.0 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
3.0 | 14.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.9 | 20.5 | GO:0043199 | sulfate binding(GO:0043199) |
2.9 | 37.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
2.9 | 14.3 | GO:0048495 | Roundabout binding(GO:0048495) |
2.9 | 20.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
2.8 | 14.2 | GO:0043426 | MRF binding(GO:0043426) |
2.8 | 17.0 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
2.8 | 11.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
2.8 | 16.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
2.8 | 16.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.8 | 33.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
2.7 | 60.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.7 | 269.1 | GO:0005267 | potassium channel activity(GO:0005267) |
2.7 | 21.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
2.7 | 59.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
2.7 | 8.1 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
2.6 | 15.8 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
2.6 | 13.1 | GO:0050785 | advanced glycation end-product receptor activity(GO:0050785) |
2.6 | 5.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
2.6 | 15.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
2.6 | 7.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
2.6 | 20.7 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.6 | 10.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
2.6 | 12.8 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.6 | 12.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.6 | 12.8 | GO:0034056 | estrogen response element binding(GO:0034056) |
2.5 | 12.5 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.5 | 7.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
2.5 | 4.9 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
2.5 | 14.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
2.5 | 68.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.5 | 7.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.5 | 7.4 | GO:0016403 | dimethylargininase activity(GO:0016403) |
2.4 | 36.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
2.4 | 51.2 | GO:0043236 | laminin binding(GO:0043236) |
2.4 | 63.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
2.4 | 17.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.4 | 109.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
2.4 | 7.3 | GO:2001070 | starch binding(GO:2001070) |
2.4 | 65.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
2.4 | 7.2 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
2.4 | 14.4 | GO:0070538 | oleic acid binding(GO:0070538) |
2.4 | 42.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
2.3 | 37.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
2.3 | 11.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
2.3 | 34.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
2.3 | 11.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
2.3 | 63.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.2 | 4.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
2.2 | 66.9 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
2.2 | 4.5 | GO:0070573 | bradykinin receptor binding(GO:0031711) metallodipeptidase activity(GO:0070573) |
2.2 | 10.9 | GO:0097016 | L27 domain binding(GO:0097016) |
2.2 | 32.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
2.2 | 19.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.2 | 45.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
2.2 | 190.1 | GO:0044325 | ion channel binding(GO:0044325) |
2.2 | 4.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
2.1 | 8.6 | GO:0047756 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
2.1 | 6.4 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
2.1 | 63.7 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
2.1 | 105.9 | GO:0005518 | collagen binding(GO:0005518) |
2.1 | 14.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
2.1 | 187.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
2.1 | 8.3 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
2.1 | 2.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
2.1 | 6.2 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
2.1 | 8.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
2.1 | 8.2 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
2.0 | 2.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
2.0 | 10.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
2.0 | 10.0 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
2.0 | 8.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.0 | 10.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.0 | 9.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
2.0 | 9.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
1.9 | 5.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
1.9 | 1.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.9 | 15.4 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.9 | 9.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.9 | 7.6 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
1.9 | 11.4 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.9 | 22.7 | GO:0031005 | filamin binding(GO:0031005) |
1.9 | 1.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.9 | 18.9 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.9 | 18.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.8 | 3.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
1.8 | 7.2 | GO:0036033 | mediator complex binding(GO:0036033) |
1.8 | 3.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
1.8 | 10.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.7 | 5.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.7 | 8.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.7 | 10.3 | GO:0004568 | chitinase activity(GO:0004568) |
1.7 | 42.6 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
1.7 | 6.7 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.7 | 11.8 | GO:0008061 | chitin binding(GO:0008061) |
1.7 | 23.4 | GO:0005522 | profilin binding(GO:0005522) |
1.7 | 5.0 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
1.6 | 62.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
1.6 | 40.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
1.6 | 9.6 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.6 | 6.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.6 | 4.8 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
1.6 | 4.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.6 | 4.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.6 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.6 | 66.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.6 | 9.4 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
1.5 | 3.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
1.5 | 1.5 | GO:0031208 | POZ domain binding(GO:0031208) |
1.5 | 4.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.5 | 3.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.5 | 13.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
1.5 | 3.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
1.5 | 14.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.5 | 7.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
1.5 | 14.8 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
1.5 | 5.9 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.5 | 4.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.5 | 4.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.5 | 5.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.4 | 2.9 | GO:0001083 | transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) |
1.4 | 45.7 | GO:0019894 | kinesin binding(GO:0019894) |
1.4 | 5.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.4 | 2.8 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.4 | 9.7 | GO:0048156 | tau protein binding(GO:0048156) |
1.4 | 13.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.4 | 19.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.4 | 5.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.4 | 10.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
1.4 | 1.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
1.4 | 411.6 | GO:0015631 | tubulin binding(GO:0015631) |
1.4 | 18.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
1.3 | 9.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.3 | 3.9 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
1.3 | 6.4 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
1.3 | 5.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.3 | 118.5 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
1.3 | 5.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.3 | 5.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.3 | 7.6 | GO:0004144 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
1.2 | 3.7 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
1.2 | 3.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.2 | 9.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.2 | 3.7 | GO:0046592 | polyamine oxidase activity(GO:0046592) |
1.2 | 15.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
1.2 | 3.6 | GO:0019961 | interferon binding(GO:0019961) |
1.2 | 2.4 | GO:0043559 | insulin binding(GO:0043559) |
1.2 | 53.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.2 | 3.6 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.2 | 3.6 | GO:0052871 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
1.2 | 29.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.2 | 3.6 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
1.2 | 31.5 | GO:0017022 | myosin binding(GO:0017022) |
1.2 | 12.8 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.2 | 32.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.2 | 3.5 | GO:0008254 | 3'-nucleotidase activity(GO:0008254) |
1.1 | 22.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
1.1 | 3.4 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.1 | 3.4 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.1 | 9.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.1 | 9.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.1 | 3.3 | GO:0043394 | proteoglycan binding(GO:0043394) |
1.1 | 4.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.1 | 3.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.1 | 5.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
1.1 | 6.3 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.0 | 3.1 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
1.0 | 3.1 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
1.0 | 20.7 | GO:0030507 | spectrin binding(GO:0030507) |
1.0 | 21.6 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.0 | 7.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.0 | 5.1 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
1.0 | 2.0 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.0 | 34.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.0 | 5.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.0 | 29.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
1.0 | 12.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
1.0 | 8.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
1.0 | 6.8 | GO:0019966 | interleukin-1 binding(GO:0019966) |
1.0 | 22.2 | GO:0019905 | syntaxin binding(GO:0019905) |
0.9 | 4.7 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.9 | 4.7 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.9 | 4.7 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
0.9 | 7.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.9 | 2.8 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
0.9 | 5.5 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.9 | 2.7 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.9 | 2.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.9 | 7.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.9 | 5.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.9 | 7.0 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.9 | 10.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.9 | 17.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.8 | 2.5 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
0.8 | 22.8 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.8 | 1.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.8 | 10.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.8 | 5.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.8 | 1.7 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.8 | 4.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.8 | 1.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.8 | 7.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.8 | 4.1 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.8 | 0.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.8 | 2.4 | GO:0019002 | GMP binding(GO:0019002) |
0.8 | 96.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.8 | 2.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.8 | 6.3 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.8 | 3.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.8 | 3.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.8 | 3.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.8 | 1.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.8 | 9.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 1.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.7 | 171.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.7 | 3.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 4.5 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.7 | 24.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.7 | 26.6 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.7 | 1.5 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.7 | 1.4 | GO:0042806 | fucose binding(GO:0042806) |
0.7 | 4.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.7 | 8.6 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) |
0.7 | 2.1 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
0.7 | 4.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.7 | 11.2 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.7 | 2.1 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.7 | 24.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.7 | 15.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 15.1 | GO:0005112 | Notch binding(GO:0005112) |
0.7 | 3.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.7 | 2.0 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.7 | 1.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.7 | 10.7 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.7 | 0.7 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
0.7 | 8.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 3.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 6.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 1.3 | GO:0015292 | uniporter activity(GO:0015292) |
0.6 | 3.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.6 | 6.8 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.6 | 3.7 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.6 | 24.8 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 2.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.6 | 2.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.6 | 1.2 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 4.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.6 | 11.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.6 | 6.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.6 | 14.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.6 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.5 | 1.1 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.5 | 4.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.5 | 1.6 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.5 | 2.6 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.5 | 20.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.5 | 4.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.5 | 1.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.5 | 3.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.5 | 3.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 3.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 5.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.5 | 10.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.5 | 16.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.5 | 1.5 | GO:0089720 | caspase binding(GO:0089720) |
0.5 | 1.9 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.5 | 2.4 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.5 | 7.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.5 | 2.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.5 | 43.1 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 3.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.5 | 0.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.5 | 2.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.5 | 1.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.4 | 1.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.4 | 7.1 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.4 | 1.7 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.4 | 23.0 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.4 | 2.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.4 | 4.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 1.6 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 7.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.4 | 4.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 1.5 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.4 | 2.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 159.6 | GO:0005509 | calcium ion binding(GO:0005509) |
0.4 | 73.7 | GO:0003924 | GTPase activity(GO:0003924) |
0.4 | 4.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 5.4 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.4 | 1.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.4 | 3.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 1.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.3 | 2.4 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.3 | 4.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.3 | 2.0 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.3 | 0.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 3.3 | GO:0015026 | coreceptor activity(GO:0015026) |
0.3 | 0.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.3 | 1.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.3 | 12.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 0.3 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.3 | 0.6 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.3 | 2.0 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.3 | 9.2 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.3 | 0.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 1.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.3 | 0.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.3 | 0.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 0.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.2 | 4.6 | GO:0042805 | actinin binding(GO:0042805) |
0.2 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 7.0 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 0.6 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.2 | 2.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 19.0 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.2 | 2.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 2.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 1.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.2 | 0.9 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.2 | 0.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.5 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.2 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.2 | 2.1 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 1.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.2 | 7.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 4.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 1.3 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 2.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 9.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.9 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.3 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.1 | 0.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.6 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 1.4 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.1 | 0.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.5 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.2 | GO:0035596 | methylthiotransferase activity(GO:0035596) transferase activity, transferring alkylthio groups(GO:0050497) |
0.1 | 0.4 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.3 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.5 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 14.2 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.3 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.1 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.0 | 44.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
5.0 | 34.8 | PID S1P S1P4 PATHWAY | S1P4 pathway |
4.6 | 159.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
4.3 | 178.2 | PID REELIN PATHWAY | Reelin signaling pathway |
4.3 | 177.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
3.2 | 61.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
3.1 | 65.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
3.1 | 172.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
3.0 | 42.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
2.8 | 119.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
2.7 | 46.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
2.4 | 40.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
2.2 | 68.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
2.2 | 93.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
2.2 | 4.3 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
2.1 | 10.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
2.1 | 33.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
2.1 | 35.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
2.0 | 18.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.9 | 50.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
1.9 | 26.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.8 | 25.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.8 | 63.3 | PID RAS PATHWAY | Regulation of Ras family activation |
1.7 | 21.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.6 | 327.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
1.6 | 46.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.4 | 15.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.4 | 31.6 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
1.4 | 15.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.4 | 66.9 | PID LKB1 PATHWAY | LKB1 signaling events |
1.3 | 10.4 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.3 | 53.2 | PID BMP PATHWAY | BMP receptor signaling |
1.3 | 38.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.2 | 40.0 | PID RHOA PATHWAY | RhoA signaling pathway |
1.2 | 4.8 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.2 | 11.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
1.2 | 173.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
1.1 | 18.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
1.1 | 16.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.1 | 61.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
1.1 | 59.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.1 | 35.8 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
1.1 | 2.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.1 | 2.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.0 | 9.3 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
1.0 | 27.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.0 | 5.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 22.6 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.8 | 0.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.8 | 1.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.8 | 5.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 2.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.8 | 5.4 | PID FOXO PATHWAY | FoxO family signaling |
0.8 | 23.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.7 | 12.9 | PID P73PATHWAY | p73 transcription factor network |
0.7 | 5.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 10.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 10.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.7 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.6 | 7.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.6 | 10.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.6 | 7.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.6 | 2.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.5 | 10.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.5 | 120.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 3.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.5 | 10.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 8.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 3.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.4 | 11.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 3.3 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 29.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.3 | 2.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 3.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.3 | 7.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.3 | 2.0 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 6.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 2.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 5.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 10.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 3.3 | PID AURORA A PATHWAY | Aurora A signaling |
0.2 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 50.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.2 | 1.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 0.9 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 1.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
20.4 | 347.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
11.4 | 215.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
11.1 | 421.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
8.9 | 134.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
7.4 | 259.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
7.0 | 302.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
6.9 | 338.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
6.8 | 250.2 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
6.6 | 6.6 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
6.3 | 31.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
6.3 | 157.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
6.3 | 94.1 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
5.3 | 112.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
5.1 | 60.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
5.0 | 60.0 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
4.7 | 23.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
4.7 | 103.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
4.6 | 178.3 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
4.5 | 112.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
4.5 | 53.6 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
4.2 | 33.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
4.2 | 20.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
4.1 | 74.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.9 | 61.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
3.9 | 77.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
3.7 | 48.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
3.5 | 46.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.5 | 62.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
3.3 | 46.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
3.1 | 12.2 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
2.9 | 213.8 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
2.7 | 40.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
2.7 | 80.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
2.6 | 44.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
2.6 | 20.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
2.5 | 47.7 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.5 | 27.5 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
2.4 | 61.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
2.4 | 60.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
2.4 | 26.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.4 | 49.5 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
2.3 | 16.3 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
2.2 | 15.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.2 | 4.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
2.1 | 4.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.0 | 14.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.8 | 25.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
1.8 | 1.8 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.8 | 7.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.8 | 67.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.8 | 10.7 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
1.7 | 48.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.7 | 39.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
1.7 | 37.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.6 | 28.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.6 | 11.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.6 | 12.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.5 | 9.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.5 | 33.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.5 | 36.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.5 | 51.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.4 | 36.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
1.4 | 33.1 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
1.4 | 19.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.3 | 22.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.3 | 16.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
1.3 | 34.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
1.2 | 8.5 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.2 | 17.3 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.1 | 21.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.1 | 15.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.1 | 4.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
1.1 | 5.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.1 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
1.1 | 1.1 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.0 | 28.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.0 | 23.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
1.0 | 19.8 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.0 | 12.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
1.0 | 15.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.0 | 9.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.9 | 11.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.9 | 9.0 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.9 | 68.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.9 | 7.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.9 | 11.1 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.9 | 9.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.9 | 11.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 13.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.8 | 38.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.8 | 3.2 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 49.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.8 | 11.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.7 | 81.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.7 | 11.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.7 | 16.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.7 | 6.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.7 | 5.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.7 | 13.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.6 | 7.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.6 | 8.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.6 | 11.4 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.6 | 1.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.6 | 9.7 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.6 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.6 | 19.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.6 | 1.7 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.6 | 11.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 57.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.5 | 26.9 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.5 | 12.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.5 | 4.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.5 | 3.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 28.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.4 | 17.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 3.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.4 | 4.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.4 | 6.2 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 0.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 2.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 2.9 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.3 | 3.8 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.2 | 3.9 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.2 | 4.8 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.2 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.2 | 1.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 4.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.1 | 0.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.9 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.1 | 2.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.1 | 3.1 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 0.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 0.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 3.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 0.7 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |